Literature DB >> 9882616

Enhancement of chemotactic peptide-induced activation of phosphoinositide 3-kinase by granulocyte-macrophage colony-stimulating factor and its relation to the cytokine-mediated priming of neutrophil superoxide-anion production.

T Kodama1, K Hazeki, O Hazeki, T Okada, M Ui.   

Abstract

Incubation of human neutrophils with a chemotactic peptide [N-formylmethionyl-leucylphenylalanine (fMLP)] gave rise to an increase in the phosphoinositide 3-kinase (PI3K) activity, phosphorylation of p47phox and superoxide-anion (O2(-)) generation in the same fMLP-concentration-dependent manner. These responses to fMLP were markedly enhanced when the cells had been incubated for 10 min before the addition of fMLP with increasing concentrations of granulocyte-macrophage colony-stimulating factor (GM-CSF) that were only slightly effective themselves. Wortmannin, an inhibitor of PI3K, suppressed all of these fMLP actions in the same concentration-dependent manner in either GM-CSF-primed or non-primed cells. Sustained activation of protein kinase C by the addition of PMA caused marked phosphorylation of p47phox and respiratory burst itself without activation of PI3K. This strong action of PMA was not primed by GM-CSF. The chemotactic peptide was without effect in pertussis-toxin-treated cells, indicating that its actions are mediated by betagamma-subunits liberated from toxin-susceptible heterotrimeric Gi proteins (Gbetagamma). Thus one of the mechanisms of GM-CSF-mediated priming of fMLP-induced respiratory burst is synergistic activation of wortmannin-sensitive PI3K by Gbetagamma in the presence of tyrosine-phosphorylated proteins in GM-CSF-treated cells, as recently indicated in a cell-free system [Kurosu, Maehama, Okada, Yamamoto, Hoshino, Fukui, Ui, Hazeki and Katada (1997) J. Biol. Chem. 272, 24252-24256]. GM-CSF primed fMLP-induced MAP (mitogen-activated protein) kinase activation enormously as well. The MAP kinase activation was primed even in the presence of wortmannin, indicating that PI3K was not the sole site where tyrosine kinase-related and Gbetagamma-mediated intracellular signals converge to elicit the priming. The GM-CSF priming of fMLP-induced PI3K activation and O2(-) generation was much smaller in magnitude in neutrophils in which cAMP accumulated upon incubation with prostaglandin E1 than in the cells without the nucleotide accumulation. Thus the GM-CSF priming site, in addition to PI3K, might be just the target of cAMP-dependent protein kinase A in fMLP-initiated signalling cascades or could be localized immediately downstream thereof.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9882616      PMCID: PMC1219953     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  42 in total

1.  Synergistic activation of PtdIns 3-kinase by tyrosine-phosphorylated peptide and beta gamma-subunits of GTP-binding proteins.

Authors:  T Okada; O Hazeki; M Ui; T Katada
Journal:  Biochem J       Date:  1996-07-15       Impact factor: 3.857

2.  Inhibition of neutrophil oxidative burst and granule secretion by wortmannin: potential role of MAP kinase and renaturable kinases.

Authors:  A K Sue-A-Quan; L Fialkow; C J Vlahos; J A Schelm; S Grinstein; J Butler; G P Downey
Journal:  J Cell Physiol       Date:  1997-07       Impact factor: 6.384

3.  Heterodimeric phosphoinositide 3-kinase consisting of p85 and p110beta is synergistically activated by the betagamma subunits of G proteins and phosphotyrosyl peptide.

Authors:  H Kurosu; T Maehama; T Okada; T Yamamoto; S Hoshino; Y Fukui; M Ui; O Hazeki; T Katada
Journal:  J Biol Chem       Date:  1997-09-26       Impact factor: 5.157

4.  The G beta gamma sensitivity of a PI3K is dependent upon a tightly associated adaptor, p101.

Authors:  L R Stephens; A Eguinoa; H Erdjument-Bromage; M Lui; F Cooke; J Coadwell; A S Smrcka; M Thelen; K Cadwallader; P Tempst; P T Hawkins
Journal:  Cell       Date:  1997-04-04       Impact factor: 41.582

5.  Phosphatidylinositol 3-kinase-dependent activation of protein kinase C-zeta in bacterial lipopolysaccharide-treated human monocytes.

Authors:  P Herrera-Velit; K L Knutson; N E Reiner
Journal:  J Biol Chem       Date:  1997-06-27       Impact factor: 5.157

6.  c-kit receptor signaling through its phosphatidylinositide-3'-kinase-binding site and protein kinase C: role in mast cell enhancement of degranulation, adhesion, and membrane ruffling.

Authors:  K Vosseller; G Stella; N S Yee; P Besmer
Journal:  Mol Biol Cell       Date:  1997-05       Impact factor: 4.138

7.  Linkage of G protein-coupled receptors to the MAPK signaling pathway through PI 3-kinase gamma.

Authors:  M Lopez-Ilasaca; P Crespo; P G Pellici; J S Gutkind; R Wetzker
Journal:  Science       Date:  1997-01-17       Impact factor: 47.728

8.  Chemotactic peptide N-formyl-met-leu-phe activation of p38 mitogen-activated protein kinase (MAPK) and MAPK-activated protein kinase-2 in human neutrophils.

Authors:  E Krump; J S Sanghera; S L Pelech; W Furuya; S Grinstein
Journal:  J Biol Chem       Date:  1997-01-10       Impact factor: 5.157

9.  Cyclic AMP-increasing agents interfere with chemoattractant-induced respiratory burst in neutrophils as a result of the inhibition of phosphatidylinositol 3-kinase rather than receptor-operated Ca2+ influx.

Authors:  M U Ahmed; K Hazeki; O Hazeki; T Katada; M Ui
Journal:  J Biol Chem       Date:  1995-10-06       Impact factor: 5.157

10.  Specific association of phosphatidylinositol 3-kinase with the protooncogene product Cbl in Fc gamma receptor signaling.

Authors:  T Matsuo; K Hazeki; O Hazeki; T Katada; M Ui
Journal:  FEBS Lett       Date:  1996-03-11       Impact factor: 4.124

View more
  9 in total

Review 1.  Current understanding of Pneumocystis immunology.

Authors:  Michelle N Kelly; Judd E Shellito
Journal:  Future Microbiol       Date:  2010-01       Impact factor: 3.165

2.  A specific p47phox -serine phosphorylated by convergent MAPKs mediates neutrophil NADPH oxidase priming at inflammatory sites.

Authors:  Pham My-Chan Dang; Allan Stensballe; Tarek Boussetta; Houssam Raad; Cedric Dewas; Yolande Kroviarski; Gilles Hayem; Ole N Jensen; Marie-Anne Gougerot-Pocidalo; Jamel El-Benna
Journal:  J Clin Invest       Date:  2006-06-15       Impact factor: 14.808

3.  A novel function for fibroblast growth factor 21: stimulation of NADPH oxidase-dependent ROS generation.

Authors:  Wen-fei Wang; Lei Ma; Ming-yao Liu; Ting-ting Zhao; Tong Zhang; Yong-bi Yang; Hong-xue Cao; Xiao-hui Han; De-shan Li
Journal:  Endocrine       Date:  2014-12-27       Impact factor: 3.633

4.  Macrophage stimulating protein (MSP) evokes superoxide anion production by human macrophages of different origin.

Authors:  S Brunelleschi; L Penengo; L Lavagno; C Santoro; D Colangelo; I Viano; G Gaudino
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

Review 5.  International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family.

Authors:  Richard D Ye; François Boulay; Ji Ming Wang; Claes Dahlgren; Craig Gerard; Marc Parmentier; Charles N Serhan; Philip M Murphy
Journal:  Pharmacol Rev       Date:  2009-06-04       Impact factor: 25.468

6.  Signaling mechanisms of enhanced neutrophil phagocytosis and chemotaxis by the polysaccharide purified from Ganoderma lucidum.

Authors:  Ming-Jen Hsu; Shiuh-Sheng Lee; Sho Tone Lee; Wan-Wan Lin
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

Review 7.  Priming of the neutrophil NADPH oxidase activation: role of p47phox phosphorylation and NOX2 mobilization to the plasma membrane.

Authors:  Jamel El-Benna; Pham My-Chan Dang; Marie-Anne Gougerot-Pocidalo
Journal:  Semin Immunopathol       Date:  2008-06-07       Impact factor: 9.623

8.  Effects of decreased calmodulin protein on the survival mechanisms of alveolar macrophages during Pneumocystis pneumonia.

Authors:  Mark E Lasbury; Pamela J Durant; Chung-Ping Liao; Chao-Hung Lee
Journal:  Infect Immun       Date:  2009-06-01       Impact factor: 3.441

9.  Increased reactive oxygen species production and p47phox phosphorylation in neutrophils from myeloproliferative disorders patients with JAK2 (V617F) mutation.

Authors:  Margarita Hurtado-Nedelec; Marie-José Csillag-Grange; Tarek Boussetta; Sahra Amel Belambri; Michèle Fay; Bruno Cassinat; Marie-Anne Gougerot-Pocidalo; Pham My-Chan Dang; Jamel El-Benna
Journal:  Haematologica       Date:  2013-08-23       Impact factor: 9.941

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.